The Motley Fool··Jack DelaneyBristol Myers Squibb Offers Dividend Appeal, But Patent Cliff Looms Large
Bristol Myers Squibb trades at attractive 9.5x forward P/E with 4.2% yield and 17 years of dividend hikes, but faces revenue declines and patent expiration risks.
BMYCELGrJNJMRKvalue investingdividend stocks